N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide

C26H28BrN7O3 — CID 141482950

IUPACN-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide
SMILESC=CC(=O)Nc1cccc(Nc2ncc(Br)c(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)n2)c1
InChIInChI=1S/C26H28BrN7O3/c1-4-24(36)29-18-6-5-7-19(14-18)30-26-28-16-21(27)25(32-26)31-22-9-8-20(15-23(22)37-3)34-12-10-33(11-13-34)17(2)35/h4-9,14-16H,1,10-13H2,2-3H3,(H,29,36)(H2,28,30,31,32)
InChIKeyVHBDGDZYBSQVCF-UHFFFAOYSA-N
MW566.46 g/mol
LogP4.53
Rot. Bonds8

About N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide

N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide (PubChem CID 141482950) has the molecular formula C26H28BrN7O3 and a molecular weight of 566.46 g/mol. Its IUPAC name is N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide.

Molecular Properties

Compound NameN-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide
PubChem CID141482950
Molecular FormulaC26H28BrN7O3
Molecular Weight566.46 g/mol
Exact Mass565.14
IUPAC NameN-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide
SMILESC=CC(=O)Nc1cccc(Nc2ncc(Br)c(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)n2)c1
InChIInChI=1S/C26H28BrN7O3/c1-4-24(36)29-18-6-5-7-19(14-18)30-26-28-16-21(27)25(32-26)31-22-9-8-20(15-23(22)37-3)34-12-10-33(11-13-34)17(2)35/h4-9,14-16H,1,10-13H2,2-3H3,(H,29,36)(H2,28,30,31,32)
InChIKeyVHBDGDZYBSQVCF-UHFFFAOYSA-N
XLogP4.53
TPSA111.72 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500566.46
LogP ≤ 54.53
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide?
The IUPAC name of N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide (CID 141482950) is N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide.
What is the SMILES notation for N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide?
The canonical SMILES for N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide is C=CC(=O)Nc1cccc(Nc2ncc(Br)c(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)n2)c1.
What is the InChIKey of N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide?
The InChIKey is VHBDGDZYBSQVCF-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H28BrN7O3/c1-4-24(36)29-18-6-5-7-19(14-18)30-26-28-16-21(27)25(32-26)31-22-9-8-20(15-23(22)37-3)34-12-10-33(11-13-34)17(2)35/h4-9,14-16H,1,10-13H2,2-3H3,(H,29,36)(H2,28,30,31,32).
What are the key properties of N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide?
N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide has a molecular weight of 566.46 g/mol, XLogP of 4.53, 8 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[[4-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-bromopyrimidin-2-yl]amino]phenyl]prop-2-enamide is sourced from PubChem (CID 141482950), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).